Ikarian Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 114 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 134 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 136 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 111 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 96 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 89 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 95 |
|
|
2023
Q2 | – | Sell |
-106,057
| Closed | -$3.82M | – | 96 |
|
|
2023
Q1 | $3.82M | Sell |
106,057
-161,419
| -60% | -$5.81M | 0.87% | 25 |
|
|
2022
Q4 | $11.9M | Sell |
267,476
-50,000
| -16% | -$2.23M | 2.88% | 4 |
|
|
2022
Q3 | $8.92M | Sell |
317,476
-220,482
| -41% | -$6.2M | 1.78% | 6 |
|
|
2022
Q2 | $14.5M | Hold |
537,958
| – | – | 2.64% | 1 |
|
|
2022
Q1 | $18.3M | Buy |
537,958
+118,742
| +28% | +$4.04M | 2.41% | 2 |
|
|
2021
Q4 | $16.2M | Buy |
419,216
+148,785
| +55% | +$5.75M | 2.41% | 3 |
|
|
2021
Q3 | $14.6M | Sell |
270,431
-95,113
| -26% | -$5.13M | 1.03% | 3 |
|
|
2021
Q2 | $12.2M | Sell |
365,544
-230,746
| -39% | -$7.72M | 0.99% | 9 |
|
|
2021
Q1 | $12.3M | Sell |
596,290
-768,700
| -56% | -$15.8M | 0.41% | 8 |
|
|
2020
Q4 | $23.9M | Sell |
1,364,990
-104,740
| -7% | -$1.84M | 1.05% | 2 |
|
|
2020
Q3 | $21.8M | Sell |
1,469,730
-177,709
| -11% | -$2.64M | 1.58% | 1 |
|
|
2020
Q2 | $21.4M | Buy |
+1,647,439
| New | +$21.4M | 1.7% | 1 |
|